Skip navigation

Search results for the care act 2014

Showing 1051 to 1065 of 2102 results

New Equality, Diversity and Inclusion plan approved by Council

A bold new action plan setting out the ways in which HCPC will deliver on our commitments to equality, diversity and inclusion (EDI) has been approved by the HCPC’s Council.

Promoting public health and preventing ill-health

We have introduced new standards about promoting public health and preventing ill-health. This is one theme within the key changes to the updated standards of proficiency for all professions. 

Preceptorship for internationally recruited registrants

For HCPC registrants who have come to work in the UK via our international registration route, preceptorship can provide a way to support acculturation to both their new working environment and to living in the UK.

Upskilling and training responsibilities

Our changes provide further guidance around scope of practice and highlight the need to make sure registrants have the knowledge, skills and experience to practise safely and effectively. 

Diversity data: hearing aid dispensers - March 2023

This factsheet provides key EDI information for hearing aid dispensers and how the demographics of this group compare to the demographics of HCPC registrants overall

NHS England Prescribing and Support Assurance Framework

NHS England, in collaboration with stakeholders across the UK including HCPC, has developed a framework to demonstrate the resources, governance measures, considerations and responsibilities in place to ensure and assure safe prescribing.

Historical programmes

You can apply to join the Register if you have completed a programme that was historically approved by our predecessor, the Council for Professions Supplementary to Medicine (CPSM)

Working with our stakeholders

See how we work with stakeholders, which underpins the functioning of the model

Joint statement on meeting regulatory standards during periods of global or national shortage of medicines

We are concerned to hear that people with Type 2 diabetes are experiencing problems accessing GLP-1 receptor agonists (GLP-1 RAs).

Council Meeting - 26 May 2022

Please note that item 6 will be published once the meeting has been held.